Skip to main navigation Skip to main content
Home
Menu
  • Contact Us
  • About
    • About BBCIC
    • Governance
      • Board of Managing Directors
      • Planning Board
      • Science Committee
    • Partners
    • Contact
  • Research
    • Approach
    • Range of Research
    • Research Plan
    • Research Teams
    • Our Research
    • Publications & Resources
  • News & Events
    • News
    • Events
    • Newsletters
  • Search

 

Enter your keyword(s)

Breadcrumb

  1. BBCIC
  2. About
  3. Governance
  4. Planning Board

Main navigation

  • About
    • About BBCIC
    • Governance
      • Board of Managing Directors
      • Planning Board
      • Science Committee
    • Partners
    • Contact
  • Research
  • News & Events
  • Search

Planning Board

The BBCIC Planning Board manages the consortium’s charter, operational policies and procedures, and research plans. The Planning Board oversees public communications for BBCIC activities and findings. 

BBCIC Planning Board Members

  • Chairperson: Mark Cziraky, PharmD, Co-Founder and VP of Research, Anthem/Healthcore
  • Jeffrey S. Brown, PhD, Associate Professor, Department of Population Medicine, Harvard Pilgrim Health Care Institute
  • Leah Christl, PhD, Executive Director, Global Regulatory and R&D Policy, JAPAC Lead and Global Biosimilars, Amgen
  • Jerry Clewell, PharmD, MBA, Associate Scientific Director, Biotherapeutics Strategy, AbbVie
  • Hillel Cohen, Hillel Cohen, MD, PhD, Executive Director, Scientific Affairs, Sandoz
  • Elizabeth Engelhardt, RN, MSCN, VP, Specialty Product, Aetna
  • Amy Gross, PharmD, BCPP, Director, Clinical Specialists, Express Scripts Inc
  • James Kenney, MBA, Principal, JT Kenney Consulting
  • Dottie McCabe, PhD, FCP, Executive Director, Clinical Development & Medical Affairs, General Medicine, Immunology & CNS, Boehringer-Ingelheim
  • Jeremy Whalen, PharmD, BCOP, Hematology and Oncology Pharmacy Association (HOPA)
  • Kai Yeung, PharmD, PhD, Scientific Investigator I, Kaiser Permanente of Washington Research Institute
  • Planning Board Public Representative: Jeffrey R. Curtis, MD, MS, MPH, Co-Director, UAB Center for Education and Research on Therapeutics (CERTS), University of Alabama at Birmingham
  • Planning Board Public Representative: Robert S. Miller MD, FACP,  FASCO, Vice President, Quality and Guidelines, American Society of Clinical Oncology (ASCO)
  • Planning Board Public Representative: Anna Hyde, Vice President of Advocacy and Access| Department of Advocacy and Access, Arthritis Foundation
  • FDA Liaison: Robert Ball, MD, MPH, Deputy Director, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
  • BBCIC Staff: Cate Lockhart, PharmD, PhD, Executive Director, BBCIC
  • BBCIC Staff: Cara McDermott, PharmD, PhD, Research Consultant, BBCIC
  • BBCIC Counsel: George Constantine, JD, Counsel, BBCIC
Join BBCIC
Help us monitor use, impact, safety, and clinical effectiveness of biologics and biosimilars.
Participate in BBCIC

Contact Us

Send a Message

Address

675 N Washington Street
Suite 220
Alexandria, VA 22314

Phone

703.684.2600

Menu

  • About
  • Research
  • News & Events
  • Search
BBCIC Logo
  • Antitrust
  • Privacy Policy
  • Disclaimer

© 2019 Biologics and Biosimilars Collective Intelligence Consortium (BBCIC)

  • About
    • About BBCIC
    • Governance
      • Board of Managing Directors
      • Planning Board
      • Science Committee
    • Partners
    • Contact
  • Research
    • Approach
    • Range of Research
    • Research Plan
    • Research Teams
    • Our Research
    • Publications & Resources
  • News & Events
    • News
    • Events
    • Newsletters
  • Search